Medicine and Dentistry
Alternative Complement Pathway C3 C5 Convertase
100%
Atopic Dermatitis
100%
Azathioprine
16%
Cell Signaling Pathway
14%
Clinical Trial
16%
Cyclosporine
16%
Expression Regulation
14%
extracellular signal regulated kinase
57%
Gene Expression
100%
Interleukin 8
14%
Intracellular Signaling
14%
Labor Onset
14%
Messenger RNA
28%
Methotrexate
16%
Mitogenic Agent
100%
Nuclear Factor
100%
Phosphotransferase
100%
Phototherapy
16%
Premature Labor
14%
Primary Culture
14%
Prostaglandin H
14%
Randomized Controlled Trial
16%
Receptor
14%
Smooth Muscle Cell
28%
Synthetase
14%
Systemic Therapy
100%
Topical Treatment
16%
Tumor Necrosis Factor
100%
Tumor Necrosis Factor Receptor
100%
Immunology and Microbiology
Adaptive Immune System
50%
Atopic Dermatitis
100%
Azathioprine
16%
Ciclosporin
16%
Cytokine
50%
Immunopathogenesis
50%
Immunotherapy
100%
Innate Immune System
50%
Methotrexate
16%
Skin Flora
50%
Skin Microbiome
50%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
100%
Azathioprine
16%
Ciclosporin
16%
Clinical Trial
16%
Methotrexate
16%
Randomized Controlled Trial
16%